These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 19054549)

  • 21. Human papillomavirus types 16 and 18 mRNA levels and not DNA levels may be associated with advancing stages of cervical cancer.
    Gnanamony M; Peedicayil A; Subhashini J; Ram TS; Christopher S; Gravitt P; Abraham P
    Int J Gynecol Cancer; 2009 Nov; 19(8):1415-20. PubMed ID: 20009900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes.
    Verhoef VM; van Kemenade FJ; Rozendaal L; Heideman DA; Bosgraaf RP; Hesselink AT; Melchers WJ; Massuger LF; Bekkers RL; Steenbergen RD; Berkhof J; Snijders PJ; Meijer CJ
    Gynecol Oncol; 2015 Apr; 137(1):55-9. PubMed ID: 25667975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of human papillomavirus genotype by linear array assay in Japanese women with uterine cervical lesions and type 16 physical status by in situ hybridization.
    Futai M; Watanabe J; Jobo T; Tsunoda S; Nishimura Y; Watanabe K; Okayasu I; Unno N
    Int J Gynecol Cancer; 2009 Nov; 19(8):1396-401. PubMed ID: 20009896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PAX1 methylation as a potential biomarker for cervical cancer screening.
    Kan YY; Liou YL; Wang HJ; Chen CY; Sung LC; Chang CF; Liao CI
    Int J Gynecol Cancer; 2014 Jun; 24(5):928-34. PubMed ID: 24844223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide DNA methylation profiling identifies two novel genes in cervical neoplasia.
    El-Zein M; Cheishvili D; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Szyf M; Franco EL;
    Int J Cancer; 2020 Sep; 147(5):1264-1274. PubMed ID: 31983058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.
    Syrjänen K; Shabalova I; Naud P; Kozachenko V; Derchain S; Zakharchenko S; Roteli-Martins C; Nerovjna R; Longatto-Filho A; Kljukina L; Tatti S; Branovskaja M; Hammes LS; Branca M; Grunjberga V; Erzen M; Sarian LO; Juschenko A; Costa S; Podistov J; Syrjänen S;
    Int J Gynecol Cancer; 2009 Jul; 19(5):934-42. PubMed ID: 19574788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study.
    Salta S; Maia-Moço L; Estevão-Pereira H; Sequeira JP; Vieira R; Bartosch C; Petronilho S; Monteiro P; Sousa A; Baldaque I; Rodrigues J; Sousa H; Tavares F; Henrique R; Jerónimo C
    Int J Cancer; 2021 Dec; 149(11):1916-1925. PubMed ID: 34460099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between Gene Promoter Methylation and Cervical Cancer Development: Global Distribution and A Meta-analysis.
    El Aliani A; El-Abid H; El Mallali Y; Attaleb M; Ennaji MM; El Mzibri M
    Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):450-459. PubMed ID: 33441308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the hybrid capture II assay with the human papillomavirus DNA chip test for the detection of high-grade cervical lesions.
    Kang WD; Kim CH; Cho MK; Kim JW; Kim YH; Choi HS; Kim SM
    Int J Gynecol Cancer; 2009 Jul; 19(5):924-8. PubMed ID: 19574786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.
    Banzai C; Nishino K; Quan J; Yoshihara K; Sekine M; Yahata T; Tanaka K;
    Int J Clin Oncol; 2014 Feb; 19(1):127-32. PubMed ID: 23494221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review.
    Kremer WW; Steenbergen R; Heideman D; Kenter GG; Meijer C
    BJOG; 2021 Feb; 128(3):504-514. PubMed ID: 32619334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RASSF1A promoter methylation was associated with the development, progression and metastasis of cervical carcinoma: a meta-analysis with trial sequential analysis.
    Zheng F; Yu H
    Arch Gynecol Obstet; 2018 Feb; 297(2):467-477. PubMed ID: 29288321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias.
    Lai HC; Lin YW; Chang CC; Wang HC; Chu TW; Yu MH; Chu TY
    Gynecol Oncol; 2007 Mar; 104(3):629-35. PubMed ID: 17097722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.
    van Kempen PM; van Bockel L; Braunius WW; Moelans CB; van Olst M; de Jong R; Stegeman I; van Diest PJ; Grolman W; Willems SM
    Cancer Med; 2014 Oct; 3(5):1185-96. PubMed ID: 25065733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.
    Gage JC; Hunt WC; Schiffman M; Katki HA; Cheung LC; Cuzick J; Myers O; Castle PE; Wheeler CM;
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):36-42. PubMed ID: 26518316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer.
    Verlaat W; Van Leeuwen RW; Novianti PW; Schuuring E; Meijer CJLM; Van Der Zee AGJ; Snijders PJF; Heideman DAM; Steenbergen RDM; Wisman GBA
    Epigenetics; 2018; 13(7):769-778. PubMed ID: 30079796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
    Hesselink AT; Heideman DA; Steenbergen RD; Coupé VM; Overmeer RM; Rijkaart D; Berkhof J; Meijer CJ; Snijders PJ
    Clin Cancer Res; 2011 Apr; 17(8):2459-65. PubMed ID: 21389098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-based case-control study on DAPK1, RAR-β2 and MGMT methylation in liquid-based cytology.
    Sun LL; Cao DY; Yang JX; Li H; Zhou XR; Song ZQ; Cheng XM; Chen J; Shen K
    Arch Gynecol Obstet; 2012 May; 285(5):1433-9. PubMed ID: 22116316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delta-Like Ligand-Notch1 Signaling Is Selectively Modulated by HPV16 E6 to Promote Squamous Cell Proliferation and Correlates with Cervical Cancer Prognosis.
    Khelil M; Griffin H; Bleeker MCG; Steenbergen RDM; Zheng K; Saunders-Wood T; Samuels S; Rotman J; Vos W; van den Akker BE; de Menezes RX; Kenter GG; Doorbar J; Jordanova ES
    Cancer Res; 2021 Apr; 81(7):1909-1921. PubMed ID: 33500246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DAPK1, MGMT and RARB promoter methylation as biomarkers for high-grade cervical lesions.
    Sun Y; Li S; Shen K; Ye S; Cao D; Yang J
    Int J Clin Exp Pathol; 2015; 8(11):14939-45. PubMed ID: 26823825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.